Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019

SELL
$126.95 - $142.14 $596,665 - $668,057
-4,700 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$125.72 - $139.79 $1.46 Million - $1.62 Million
-11,600 Reduced 71.17%
4,700 $657,000
Q4 2018

Feb 12, 2019

SELL
$122.84 - $147.84 $34.3 Million - $41.3 Million
-279,400 Reduced 94.49%
16,300 $2.1 Million
Q3 2018

Nov 13, 2018

SELL
$121.58 - $142.88 $29.2 Million - $34.3 Million
-240,000 Reduced 44.8%
295,700 $40.9 Million
Q2 2018

Aug 13, 2018

SELL
$119.4 - $131.76 $44.6 Million - $49.2 Million
-373,775 Reduced 41.1%
535,700 $65 Million
Q1 2018

May 14, 2018

SELL
$125.1 - $148.14 $1.48 Million - $1.76 Million
-11,848 Reduced 1.29%
909,475 $117 Million
Q4 2017

Feb 13, 2018

SELL
$131.22 - $143.62 $380,800 - $416,785
-2,902 Reduced 0.31%
921,323 $129 Million
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $120 Million - $125 Million
924,225
924,225 $120 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Primecap Management CO Portfolio

Follow Primecap Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.